Why is Intel stock sliding today?

Intel shares fell 5.7% to $62.01 after Q4 2026 guidance projected revenue of $15–$16 billion and adjusted EPS of $0.25, below analyst expectations of about $17.1 billion and $0.44. Multiple firms downgraded the stock or cut price targets; management also warned PC weakness could persist through at least H1 2027. An incident at Intel’s Israel manufacturing facility is projected to disrupt $300–$600 million in revenue, while the S&P 500 and Nasdaq posted modest gains.

Analysis

The key risk is not just a weak PC quarter: a lower near-term revenue base can reduce factory utilization while Intel is still trying to establish foundry credibility. That combination can pressure margins and make external customers less willing to commit to a manufacturing roadmap—an adverse feedback loop that a one-quarter revenue disruption alone would not capture. The facility impact is a company estimate; duration, product mix and any knock-on effect on customer shipments need verification.

Over days, analyst downgrades and estimate resets can extend forced selling, but after an exceptional prior-session decline, chasing an outright short has poor entry asymmetry. Over 1–3 months, the decisive evidence is whether Intel’s next guidance stabilizes and whether PC demand or manufacturing execution improves; 6–18 months, sustained foundry slippage could shift incremental CPU share toward AMD and reinforce reliance on external foundries such as TSMC. AMD is not a clean hedge: a shrinking PC market can limit share-gain monetization, while its own shares may remain exposed to sector de-risking. NVIDIA’s relative resilience is not proof of insulation across semiconductors.

Contrarian angle: the Israel disruption may be temporary and partly recoverable, so treating the full estimated impact as permanent would overstate damage. But even a full recovery would not fix the broader guide-down or utilization risk. No valuation or consensus detail is provided to establish that the selloff is overdone.

Key Decisions for Investors

• Avoid adding to an outright INTC short after the sharp repricing. Reassess after estimate revisions and price action settle; the thesis weakens if Intel stabilizes its revenue/EPS outlook and demonstrates recovery of disrupted output without further execution setbacks.
• For a 1–3 month relative-value expression, consider a small, beta-aware short INTC / long AMD pair only if the objective is relative execution and share capture—not a broad PC rebound. Keep sizing modest: weak PC demand can hurt both legs, and AMD may not monetize share gains quickly.
• Track the next Intel guidance update, PC demand indicators, facility recovery timing and any evidence of customer or foundry-roadmap delays. Further cuts to forward revenue/EPS or a prolonged disruption would strengthen the downside case; confirmed output recovery and stable guidance would invalidate it.
• Do not infer a broad semiconductor short from this event alone. Treat MU weakness as potential sector spillover unless memory-specific fundamentals deteriorate; NVDA’s relative strength may reflect different demand drivers rather than a sector-wide all-clear.